Should patients with symptomatic BPH have a trial of medical therapy by their general practitioner prior to referral for urological assessment?

Irish Medical Journal

Volumn 100, Issue 4, 2007, Pages

  McGuire, Barry ^b   O'Brien, M F ^b   Fitzpatrick, John M ^a   O'Malley, Kiaran J ^b   McLoughlin, S ^b  

^a University Hospital   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; STEROID 5ALPHA REDUCTASE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; BLADDER SURGERY; CLINICAL ASSESSMENT; CYSTOSCOPY; DISEASE SEVERITY; GENERAL PRACTICE; HEALTH EDUCATION; HUMAN; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PATIENT REFERRAL; PRESCRIPTION; PRIMARY MEDICAL CARE; PROSTATE HYPERTROPHY; RESIDUAL URINE; SYMPTOMATOLOGY; TRANSURETHRAL RESECTION; URODYNAMICS; UROFLOWMETRY; UROLOGIC EXAMINATION; UROLOGY; ALGORITHM; MICTURITION; MICTURITION DISORDER; MIDDLE AGED; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVALENCE; PROSPECTIVE STUDY; STANDARD;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ALGORITHMS; FAMILY PRACTICE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES; PREVALENCE; PROSPECTIVE STUDIES; PROSTATIC HYPERPLASIA; REFERRAL AND CONSULTATION; URINATION; URINATION DISORDERS;

EID: 34249787022     PISSN: 03323102     EISSN: 03323102     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Berry, S.J., D.S. Coffey, P.C. Walsh, and L.L. Ewing: The development of human benign prostatic hyperplasia with age. J Urol, 1984 132: p. 474-479.
2. Barry, M.J., A.T. Cockett, H.L. Holtgrewe, J.D. McConnell, S.A. Sihelnik, and H.N. Winfield: Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia. J Urol, 1993 150: p. 351-358.
3. Verhamme, K.M., J.P. Dieleman, G.S. Bleumink, J. van der Lei, M.C. Sturkenboom, W. Artibani, et al.: Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care - the Triumph project. Eur Urol, 2002 42: p. 323-328.
4. McNicholas, T.A.: Management of symptomatic BPH in the UK: who is treated and how? Eur Urol, 1999 36 Suppl 3: p. 33-39.
5. Speakman, M.J., R.S. Kirby, A. Joyce, P. Abrams, and R. Pocock: Guideline for the primary care management of male lower urinary tract symptoms. BJU Int, 2004 93: p. 985-990.
6. Office, T.C.S., Census 2002 - 'Population by Sex and Age Group 2002'. 2002.
7. Speakman MJ, K.D., Gingell C, Yoxal H, Davidson J.: Shared care of BPH - a general practise based study. J Urol, 1996 155: p. 391.
8. Lowe, F.C., R.L. McDaniel, J.J. Chmiel, and A.L. Hillman: Economic modelling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia. Urology, 1995 46: p. 477-483.